ViroCell Biologics, a specialized CDMO in GMP viral vector manufacturing, has successfully closed an oversubscribed convertible note offering to...

Medable introduces Medable Studio, a revolutionary application that simplifies and accelerates the process of configuring, translating, and launching eClinical...

Anti-TIGIT antibodies are revolutionizing cancer treatment by targeting the immune inhibitory receptor TIGIT, expressed on T cells and NK...

Cybin, a neuropsychiatry company, recently held a successful meeting with the FDA regarding its Type B Breakthrough Therapy for...

NorthStar Medical Radioisotopes and Convergent Therapeutics have inked a contract for manufacturing services, collaborating on CONV01-α, targeted radiotherapy for...

In this insightful interview, I spoke with Gen Li, CEO of Phesi, a pioneering company focusing on AI in...

The global market for eClinical solutions, which streamline clinical trials, is projected to expand rapidly, reaching $21.9 billion by...

Alzamend Neuro partners with Massachusetts General Hospital, a renowned Harvard Medical School research facility, to conduct a groundbreaking Phase...

Summit Therapeutics‘ investigational bispecific antibody, Ivonescimab, has achieved clinically significant benefits in a Phase III trial (HARMONi-2) compared to...

Pfizer has reported positive results from a clinical trial evaluating its vaccine, ABRYSVO, in immunocompromised adults at risk of...